Clinical Trial Update: A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy. [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding study in Japanese patients evaluated obicetrapib as an adjunct to stable statin therapy for dyslipidemia/hypercholesterolemia. Results ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• Obicetrapib (obicetrapib)

Snippet

Sponsor: NewAmsterdam Pharma | Conditions: Dyslipidemia, Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2024-09-27